MTX MINERALS TECHNOLOGIES INC
Industrial Inorganic Chemicals · NYSE · SEC CIK 891014 · Fiscal year ends 12/31
Financial factors as of 2026-10-04 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.8%
TTM net income YoY-4,118.8%
TTM EPS YoY-2,650.0%
Revenue 3-yr CAGR0.3%
Net income 3-yr CAGR—
Margins
Gross margin23.9%
Operating margin-1.6%
Net margin-3.1%
FCF margin5.9%
EBITDA margin—
Returns
ROE-4.1%
ROA-1.9%
ROIC (approx.)-1.2%
Asset turnover0.62x
Leverage & solvency
Liabilities / assets54.6%
Debt / equity0.61x
Current ratio1.45x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-3.49x
Accruals ratio-8.6%
Payout ratio—
Capex / revenue4.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.07B | $2.12B |
| Cost of revenue | $1.55B | $1.57B |
| Gross profit | $518.00M | $547.70M |
| R&D expense | $22.90M | $23.00M |
| SG&A expense | $208.00M | $209.20M |
| Operating income | $47.40M | $286.50M |
| Pretax income | -$14.00M | $223.60M |
| Income tax | $4.90M | $59.40M |
| Net income | -$18.40M | $167.10M |
| EPS (basic) | -0.59 | 5.21 |
| EPS (diluted) | -0.59 | 5.17 |
| Dividends declared per share | 0.45 | 0.41 |
| Weighted avg. shares (diluted) | 31.40M | 32.30M |
| Balance sheet | ||
| Cash & equivalents | $329.00M | $333.10M |
| Short-term investments | $3.60M | $4.00M |
| Receivables | $400.10M | $385.20M |
| Inventory | $350.20M | $342.10M |
| Current assets | $1.16B | $1.13B |
| PP&E, net | $1.02B | $989.70M |
| Goodwill | $915.90M | $913.80M |
| Intangibles | $208.70M | $218.10M |
| Total assets | $3.47B | $3.39B |
| Current liabilities | $555.40M | $397.70M |
| Short-term debt | $6.30M | $6.50M |
| Long-term debt | $955.00M | $959.60M |
| Total debt | $961.30M | $966.10M |
| Total liabilities | $1.72B | $1.61B |
| Shareholders' equity | $1.71B | $1.75B |
| Net debt | $632.30M | $633.00M |
| Shares outstanding | 31.03M | 31.90M |
| Cash flow statement | ||
| Operating cash flow | $193.70M | $236.40M |
| Capital expenditure | $107.10M | $89.50M |
| Free cash flow | $86.60M | $146.90M |
| Investing cash flow | -$122.80M | -$94.50M |
| Financing cash flow | -$89.30M | -$110.40M |
| Stock-based compensation | $11.90M | $11.80M |
| Dividends paid | $14.20M | $13.20M |
| Share buybacks | $58.50M | $63.60M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.